WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (134)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diaz, J.
Right arrow Articles by Sokoloff, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diaz, J.
Right arrow Articles by Sokoloff, P.

 Previous Article  |  Next Article 

The Journal of Neuroscience, December 1, 2000, 20(23):8677-8684

Dopamine D3 Receptors Expressed by All Mesencephalic Dopamine Neurons

Jorge Diaz1, Catherine Pilon2, Bernard Le Foll2, Claude Gros2, Antoine Triller3, Jean-Charles Schwartz2, and Pierre Sokoloff2

1 Laboratoire de Physiologie, Université René Descartes, 75006 Paris, France, 2 Unité de Neurobiologie et Pharmacologie Moléculaire (Institut National de la Santé et de la Recherche Médicale U 109), Centre Paul Broca, 75014 Paris, France, and 3 Biologie Cellulaire de la Synapse Normale et Pathologique (Institut National de la Santé et de la Recherche Médicale U 497), Ecole Normale Supérieure, 75230 Paris, France

A polyclonal antibody was generated using synthetic peptides designed in a specific sequence of the rat D3 receptor (D3R). Using transfected cells expressing recombinant D3R, but not D2 receptor, this antibody labeled 45-80 kDa species in Western blot analysis, immunoprecipitated a soluble fraction of [125I]iodosulpride binding, and generated immunofluorescence, mainly in the cytoplasmic perinuclear region of the cells. In rat brain, the distribution of immunoreactivity matched that of D3R binding, revealed using [125I]R(+)trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin ([125I]7-trans-OH-PIPAT), with dense signals in the islands of Calleja and mammillary bodies, and moderate to low signals in the shell of nucleus accumbens (AccSh), frontoparietal cortex, substantia nigra (SN), ventral tegmental area (VTA) and lobules 9 and 10 of the cerebellum. Very low or no signals could be detected in other rat brain regions, including dorsal striatum, or in D3R-deficient mouse brain. Labeling of perikarya of AccSh and SN/VTA appeared with a characteristic punctuate distribution, mostly at the plasma membrane where it was not associated with synaptic boutons, as revealed by synaptophysin immunoreactivity. In SN/VTA, D3R immunoreactivity was found on afferent terminals, arising from AccSh, in which destruction of intrinsic neurons by kainate infusions produced a loss of D3R binding in both AccSh and SN/VTA. D3R-immunoreactivity was also found in all tyrosine hydroxylase (TH)-positive neurons observed in SN, VTA and A8 retrorubral fields, where it could represent D3 autoreceptors controlling dopamine neuron activities, in agreement with the elevated dopamine extracellular levels in projection areas of these neurons found in D3R-deficient mice.

Key words: nucleus accumbens shell; substantia nigra; ventral tegmental area; D3 receptor-deficient mice; tyrosine hydroxylase; synaptophysin


Copyright © 2000 Society for Neuroscience  0270-6474/00/20238677-08$05.00/0


This article has been cited by other articles:


Home page
J. Neurosci.Home page
D. H. Zald, R. L. Cowan, P. Riccardi, R. M. Baldwin, M. S. Ansari, R. Li, E. S. Shelby, C. E. Smith, M. McHugo, and R. M. Kessler
Midbrain Dopamine Receptor Availability Is Inversely Associated with Novelty-Seeking Traits in Humans
J. Neurosci., December 31, 2008; 28(53): 14372 - 14378.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Pan, C. J. Hillard, and Q.-s. Liu
D2 Dopamine Receptor Activation Facilitates Endocannabinoid-Mediated Long-Term Synaptic Depression of GABAergic Synaptic Transmission in Midbrain Dopamine Neurons via cAMP-Protein Kinase A Signaling
J. Neurosci., December 24, 2008; 28(52): 14018 - 14030.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. Koyanagi, S. Himukashi, K. Mukaida, T. Shichino, and K. Fukuda
Dopamine D2-Like Receptor in the Nucleus Accumbens Is Involved in the Antinociceptive Effect of Nitrous Oxide
Anesth. Analg., June 1, 2008; 106(6): 1904 - 1909.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Vandecasteele, J. Glowinski, J.-M. Deniau, and L. Venance
Chemical transmission between dopaminergic neuron pairs
PNAS, March 25, 2008; 105(12): 4904 - 4909.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. M. Van Kampen and C. B. Eckman
Dopamine D3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior.
J. Neurosci., July 5, 2006; 26(27): 7272 - 7280.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Chen, J. T. Kittler, S. J. Moss, and Z. Yan
Dopamine D3 Receptors Regulate GABAA Receptor Function through a Phospho-Dependent Endocytosis Mechanism in Nucleus Accumbens
J. Neurosci., March 1, 2006; 26(9): 2513 - 2521.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Jeanblanc, D.-Y. He, N. N. H. McGough, M. L. Logrip, K. Phamluong, P. H. Janak, and D. Ron
The Dopamine D3 Receptor Is Part of a Homeostatic Pathway Regulating Ethanol Consumption
J. Neurosci., February 1, 2006; 26(5): 1457 - 1464.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-M. Kim, R. R. Gainetdinov, S. A. Laporte, M. G. Caron, and L. S. Barak
G Protein-coupled Receptor Kinase Regulates Dopamine D3 Receptor Signaling by Modulating the Stability of a Receptor-Filamin-{beta}-Arrestin Complex: A CASE OF AUTORECEPTOR REGULATION
J. Biol. Chem., April 1, 2005; 280(13): 12774 - 12780.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Le Foll and S. R. Goldberg
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 875 - 883.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
A. Nurnberger, M. Rabiger, A. Mack, J. Diaz, P. Sokoloff, B. Muhlbauer, and G. Luippold
Subapical Localization of the Dopamine D3 Receptor in Proximal Tubules of the Rat Kidney
J. Histochem. Cytochem., December 1, 2004; 52(12): 1647 - 1655.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
F. Jeanneteau, O. Guillin, J. Diaz, N. Griffon, and P. Sokoloff
GIPC Recruits GAIP (RGS19) To Attenuate Dopamine D2 Receptor Signaling
Mol. Biol. Cell, November 1, 2004; 15(11): 4926 - 4937.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Beom, D. Cheong, G. Torres, M. G. Caron, and K.-M. Kim
Comparative Studies of Molecular Mechanisms of Dopamine D2 and D3 Receptors for the Activation of Extracellular Signal-regulated Kinase
J. Biol. Chem., July 2, 2004; 279(27): 28304 - 28314.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
F. Jeanneteau, J. Diaz, P. Sokoloff, and N. Griffon
Interactions of GIPC with Dopamine D2, D3 but not D4 Receptors Define a Novel Mode of Regulation of G Protein-coupled Receptors
Mol. Biol. Cell, February 1, 2004; 15(2): 696 - 705.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. Davila, Z. Yan, L. C. Craciun, D. Logothetis, and D. Sulzer
D3 Dopamine Autoreceptors Do Not Activate G-Protein-Gated Inwardly Rectifying Potassium Channel Currents in Substantia Nigra Dopamine Neurons
J. Neurosci., July 2, 2003; 23(13): 5693 - 5697.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Narita, K. Mizuo, H. Mizoguchi, M. Sakata, M. Narita, L. F. Tseng, and T. Suzuki
Molecular Evidence for the Functional Role of Dopamine D3 Receptor in the Morphine-Induced Rewarding Effect and Hyperlocomotion
J. Neurosci., February 1, 2003; 23(3): 1006 - 1012.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Schmitz, C. Schmauss, and D. Sulzer
Altered Dopamine Release and Uptake Kinetics in Mice Lacking D2 Receptors
J. Neurosci., September 15, 2002; 22(18): 8002 - 8009.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Rouge-Pont, A. Usiello, M. Benoit-Marand, F. Gonon, P. V. Piazza, and E. Borrelli
Changes in Extracellular Dopamine Induced by Morphine and Cocaine: Crucial Control by D2 Receptors
J. Neurosci., April 15, 2002; 22(8): 3293 - 3301.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-M. Kim, K. J. Valenzano, S. R. Robinson, W. D. Yao, L. S. Barak, and M. G. Caron
Differential Regulation of the Dopamine D2 and D3 Receptors by G Protein-coupled Receptor Kinases and beta -Arrestins
J. Biol. Chem., September 28, 2001; 276(40): 37409 - 37414.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-